The average cost of Mounjaro in the UK — and what the price really includes

Step 1: understand what drives the average cost of Mounjaro UK providers charge

Mounjaro is tirzepatide, a dual GIP and GLP-1 receptor agonist made by Eli Lilly. Because it is a Prescription-Only Medicine, every pen you receive must be preceded by a clinical assessment and an issued prescription. That clinical work has a cost, even if it is not always labelled as one.

UK private pricing is dose-dependent. The starter dose (2.5mg) sits at the lower end of the range you'll see quoted; the maintenance doses (10mg, 12.5mg, 15mg) sit closer to the top. Since the September 2025 list-price increase, reported private prices have broadly ranged from around £149 to £375 per four-week pen across providers. Those figures are widely reported; individual providers set their own margins, and the number you see on a landing page may or may not reflect what you pay at checkout. How recent pricing changes have affected what UK patients pay is worth reading before you compare quotes.

One thing that doesn't vary by law: the clinical requirement. A prescriber must assess your suitability. That assessment is either priced separately, bundled into the quoted amount, or, at some services, simply not happening, which is its own kind of warning sign. A fuller breakdown of Mounjaro costs covers how individual providers structure their fees.

Step 2: look past the headline figure for what it excludes

A number in large font on a website answers a narrow question. It doesn't tell you whether a consultation fee lands separately at checkout. It doesn't tell you whether aftercare is included or billed per call. It doesn't tell you whether delivery is free or added on. And it rarely tells you what happens if you need a dose review mid-month and have a question on a Sunday.

These are not trivial extras. Mounjaro treatment runs for months, not days. Gastrointestinal side effects are common in the early weeks, nausea, changes in appetite, digestion running differently than usual. Having a clinical team you can actually reach matters during that period. The full picture of Mounjaro pricing across providers goes into this in more detail, including what the NHS describes as appropriate support for people on weight-management medicines.

NHS England's guidance on weight-management injections sets out clearly that patients on these medicines benefit from ongoing clinical oversight, not just a prescription and a wave goodbye. That framing is worth holding onto when comparing prices. Everything you need to know about Mounjaro explains what the treatment involves and what ongoing support should look like.

Step 3: what nume's (what our) single price actually covers

We are not the cheapest option. That is a deliberate choice, not an oversight. Cheapest isn't a race we entered.

Our single transparent price covers the consultation, the prescription, the medicine itself sourced through the licensed UK supply chain, and free next-working-day tracked delivery via DPD. Your consultation is personally reviewed by a GPhC-registered Independent Prescriber, the same day, every time, including for repeat orders. There is no subscription pulling money from your account, no auto-renewal, no separate aftercare invoice. Every repeat order is clinically re-reviewed before anything is dispatched.

We also verify identity by photo-ID, confirm current weight on video, notify your GP in line with GPhC guidance, and check your Summary Care Record where appropriate. Those steps add time. They also add safety. Current treatment prices are listed on our treatment and consultation page, we don't print per-pen prices in body copy, partly because they vary by dose and partly because the price isn't the right thing to anchor a decision about a prescription medicine to. You can read more about how nume operates if you want to understand the service before starting.

Step 4: why 'cheapest Mounjaro' is the wrong search

The MHRA has publicly warned about fake weight-loss pens sold online and through social media. Counterfeit pens seized in the UK have, in documented cases, contained insulin rather than tirzepatide. In October 2025 the MHRA raided the first illicit UK site manufacturing counterfeit tirzepatide pens. The pattern is consistent: prices far below market, sellers operating without the infrastructure a regulated pharmacy requires, medicines supplied without a prescription and without a clinical assessment.

You can verify any online pharmacy on the GPhC register at pharmacyregulation.org. Our GPhC premises registration is 9012878. If a seller cannot point you to a verifiable register entry, that is a red flag worth taking seriously. The MHRA's Yellow Card scheme lets you report suspect sellers directly.

For a prescription medicine that requires ongoing dose adjustment and clinical oversight, the question isn't 'where is it cheapest?' It's 'where is the clinical review genuine, the supply chain verifiable, and the support actually there when you need it?' Those factors don't show up in a headline price. What you're paying per pen breaks this down further, including how to read a provider's pricing page with the right questions in mind. If you're also curious about how much weight people typically lose each month on Mounjaro, that page offers a grounded, evidence-based picture, alongside context on what shapes results over time, and if you want to explore how those results can shift as your dose increases, what the average weight loss on Mounjaro looks like month by month gives a detailed breakdown worth reading alongside it. It's also worth knowing that tirzepatide is marketed under more than one brand name, and if you've seen references to Zepbound, what tirzepatide costs as Zepbound compared with Mounjaro explains the differences and what they mean for UK patients.